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1. Introduction 
Atopic dermatitis (AD) is a chronic inflammatory skin disorder affecting between 10-20% of 
children and 1-3% of adults in the general population. It is associated with high morbidity 
and has major public health implications. AD is associated with hyper-reactivity of the skin 
to environmental trigger factors that are harmless in normal individuals. Major contributors 
to this hyperactivity are the many immune and inflammatory changes taking place in the 
skin and peripheral blood in AD individuals. AD can be classified into several subgroups, 
each with different immune and pathological features, suggesting a multifactorial disease 
and heterogeneity. Historically two types of AD have been identified. They include the 
“extrinsic or allergic” type of AD, which is characterized by Immunoglobulin E (IgE) 
mediated sensitization (immediate, type I hypersensitivity) and occurs in 70-80% of 
individuals. The “non-allergic or intrinsic” type of AD affects 20-30% of individuals and is 
defined by a more T-cell driven feature (delayed, type IV hypersensitivity), with low IgE 
levels and absent IgE sensitization. More recently a transition from the intrinsic to the 
extrinsic type has been reported in young children, and AD individuals can show a 
combination of above mentioned phenotypes or complete absence of the known features. 
The clinical diagnosis of AD does not cause major difficulties as there are fairly well defined 
criteria. Identifying the underlying pathophysiology for the affected individual can be more 
of a challenge, as there is no gold standard test available for AD and the AD individual 
might move from one pathophysiological “type” of AD to another. Clinically AD is divided 
into acute, subacute and chronic forms with correlated histopathological changes. The 
transition from one clinical form to another is fluent and can be very rapid. AD individuals 
frequently give a personal and or a family history of asthma and allergic rhinitis, the so 
called atopic triad. Exacerbation of one of the disorders in this triad can cause concomitant 
exacerbation of the other two suggesting some underlying common pathways and 
interdependence (Reitamo et al., 2008).  
Predisposing factors for AD are multifactorial and involve genetic susceptibility, defects in 
skin barrier function, immune dysregulation, western life style and exposure to 
environmental trigger factors. The development of disease is an interplay of gene-gene and 
gene-environment interactions. The early age of onset and familial predisposition as well as 
the high concordance rate of AD in monozygotic (77%) and dizygotic (15%) twins suggest a 
www.intechopen.com
 Atopic Dermatitis – Disease Etiology and Clinical Management 
 
214 
genetically determined primary defect probably affecting the skin barrier thus playing a key 
role in the development of AD (Burns et al., 2004). The integrity of the skin barrier involves 
several components, including regulation of proteolysis of corneodesmosomes, the lipid 
lamellae and generation of natural moisturizing factor (MNF) from the breakdown products 
of the structural protein filaggrin. An imbalance of these components makes the epidermal 
barrier more susceptible to irritants, which in turn can lead to a disturbance of skin barrier 
function allowing penetration of microbes and allergens into the epidermis and dermis 
interdependence (Reitamo et al., 2008). In a recent meta-analysis filaggrin gene defects were 
shown to increase the risk of developing allergic sensitization, AD, and allergic rhinitis. The 
presence of filaggrin gene mutations correlated strongly with disease severity and treatment 
failure, and also increased the risk of asthma in AD patients (Van den Oord & Sheikh, 2009). 
IgE is composed of two identical heavy and light chains, that form the constant Fc domain 
and the antigen-binding sites, through which the IgE molecule binds to its cell surface 
receptors. Raised serum IgE levels are most commonly seen in parasitic infections as a 
defensive response. IgE mediated hypersensitivity is largely regulated by T lymphocytes. 
AD is generally thought to be due to an imbalance between Th1 and Th2 cells, with a Th2 
cell predominant immune profile in its active stage. Th2 cells produce interleukin (IL) -4, IL-
5, IL-6 and IL-13, which induce IgE production and activation of eosinophils, producing the 
acute signs and symptoms of AD.  
In general various cells contribute to the underlying pathomechanism of AD including 
Langerhans cells (LC), macrophages, T cells, B cells, keratinocytes, endothelial cells, 
eosinophils and mast cells. These cells communicate with each other in Th2 predominant 
cytokines as well as chemokines, prostanoids, proteases and reactive oxygen species 
products. High affinity IgE receptors play a crucial role in promoting this process.  
A number of environmental factors can trigger and perpetuate the inflammatory skin 
cascade in AD including irritants, foods, aeroallergens, infection. All four classic Coombs’ 
classification types of hypersensitivity (type I-IV) have been implicated in the 
pathophysiology of AD, including pseudo allergy. The hypersensitivity types can occur 
either alone or in combination in the AD individual. In the extrinsic type of AD high levels 
of specific IgE antibodies and raised total IgE levels in peripheral blood have been 
significantly associated with severity of dermatitis (Reitamo et al., 2008 & Burns et al., 2004).  
2. Trigger factors, allergens and allergy testing in atopic dermatitis 
The rate of increase in prevalence in AD in recent years is too rapid to be accounted for by 
changes in population genetics. Therefore environmental factors are the most likely 
modulating influences. The two principal aspects that have attracted attention are pollution 
and microbes. The identification of relevant pollutants that might contribute to the 
expression of atopic phenotype is still confused. Interaction with environmental microbes 
may be important in the causation of AD in a number of ways. Early-life exposure may 
condition maturation of the immune system so that apparent dysregulation associated with 
IgE production and allergy formation does not occur. Significant differences have been 
observed in the prevalence of allergies between urban and rural population within one 
country and observations confirm greater allergy sensitization in first-born and a lower 
frequency in children from large families. Evidence suggests that microbes entering via 
fecal-oral route have a greater protective effect against the development of atopic disease 
than those entering via the respiratory route (Burns et al., 2004).  
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AD has a Th2 cell predominant immune profile in its active stage. Th2 cells produce IL-4, IL-5, 
IL-6, IL-13, which induce IgE production and activation of eosinophils, producing the acute 
signs and symptoms of AD. Genetic factors, reduced bacterial stimulation in early infancy and 
a disruption in skin barrier and function are thought to contribute to the Th1-Th2 cell 
imbalance of skin in AD. Eczematous skin lesions evolve as a result of complex interactions 
between IgE bearing antigen presenting cells, T cell activation, mast cell degranulation, 
keratinocytes, eosinophils, and a combination of immediate and cellular immune response. A 
number of environmental factors have been reported to induce and perpetuate this 
inflammatory response of the skin including food and aeroallergens, microbes and irritants. 
All four classic types of hypersensitivity reactions have been implicated in the 
pathophysiology of AD including pseudo allergy. They can occur either alone or in 
combination in AD individuals (Reitamo et al., 2008 & Burns et al., 2004).    
AD is a common chronic skin condition associated with high morbidity and major public 
health implications. As prevention of disease is not yet a real option, reducing morbidity is 
main aim of treatment. Identifying the underlying pathophysiology of the individual’s AD 
is very crucial. To date no standard test is available to diagnose AD. Sensitization to various 
allergens is a major part of triggering and perpetuating the inflammatory skin response in 
AD. Various tests have been developed to investigate the underlying type(s) of 
hypersensitivity reaction(s) involved in AD patients. None of the available tests so far have 
proven sensitive and specific enough to identify reliably relevance between clinical disease 
and test result. Precise understanding of these tests including their limitations together with 
accurate correlation of patient symptoms and signs are required in order to differentiate 
between allergy, intolerances and hypersensitivities, and achieve an appropriate clinical 
diagnosis (Robinson & Smart, 2008). 
Allergy tests commonly used in practice include measurement of total levels of IgE and 
allergen specific IgE levels in serum (radio-allergosorbent test/RAST), skin prick testing 
(SPT) and atopy patch testing (APT). A different positive predictive cut off point exists for 
each allergen tested respectively and similar test results do not imply a similar clinical 
reaction to each allergen (Robinson & Smart, 2008).  
SPT is performed to detect the presence of allergen specific IgE to foods, aeroallergens, 
antibiotics and latex. A drop of a solution containing the allergen is applied to the skin and a 
lancet used to prick the skin. The allergen binds to IgE on mast cells causing degranulation 
and the release of histamine. This manifests as a weal and flare reaction, the diameter of 
which can be measured. SPT is easy to perform and results are immediately available. It can 
trigger off allergic reactions including anaphylaxis. Various medications including 
antihistamines, H2-antagonists, tricyclic antidepressants and neuroleptics can interfere with 
SPT and need to be withheld prior to testing. A positive SPT result indicates only 
sensitization and does not always equate to clinically relevant allergy. It must be interpreted 
in the context of clinical history, clinical signs and allergen exposure. The size of the weal 
does not necessarily correlate with severity of clinical reaction (Robinson & Smart, 2008 & 
Goodwin, 2008). The RAST detects free allergen specific IgE in serum. It is less sensitive and 
specific than SPT and is particularly useful where SPT is contraindicated. Testing is 
available for a wide range of food and environmental allergens. The RAST results are not 
affected by prior drug use and can be performed in patients with widespread skin disease. 
The RAST can be reported semi quantitatively as a score or as quantitative measurement by 
using the CAP RAST technology. The process involves an allergy-impregnated disc being 
incubated with patient’s serum. Allergen specific IgE, if present binds to allergen. The disc is 
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then incubated with radio-labeled anti IgE and radioactivity measured to give level of 
specific IgE present to particular allergen. Positive RAST results indicate the presence of IgE 
to an allergen or cross reacting allergen, and are difficult to interpret in the presence of high 
levels of total IgE (>1000kU/L). Results therefore must always be interpreted in the context 
of clinical history (Robinson & Smart, 2008 & Goodwin, 2008). 
APT is epicutaneous application of inhalant and food allergens on unaffected skin of AD 
individuals eliciting a delayed, type IV hypersensitivity reaction. It was traditionally 
developed to investigate association between AD and allergy to aeroallergens and proved in 
that context to have a higher specificity when compared to SPT and RAST. More recently the 
APT has been used to supplement the SPT in the diagnosis of food allergy, in an attempt to 
identify delayed reactions to food products. Reproducibility of APT results raises unsolved 
issues and is to date poor for most food allergens and good for inhalant allergens. Variables 
that can strongly influence results are allergen concentration, skin site and devices used for 
allergen application as well as reading time and/or criteria for defining positive reactions. 
These variables seem to be specific for each allergen (Lipozencić & Wolf, 2010).  
 
 
• Allergen concentration not standardized 
• Different vehicles used 
• Differences in skin sites and pre-treatment of skin 
• Differences in reading time and duration of patch testing  
 
Table 1. Factors affecting reproducibility of APT   
Patch testing (PT) is an epicutaneous and the gold standard test in the diagnosis of contact 
allergic dermatitis (CAD). It is not a routine investigation for the diagnosis of AD, but ideal 
to rule out contact allergy (e.g. to topical medication) in the presence of AD. Recent evidence 
suggests that CAD is as common in AD individuals as in the general population and PT is 
recommended in AD patients with recalcitrant disease, hand eczema and in children 
(Fonacier & Aquino, 2010). 
Oral food challenges are the “gold standard” for the diagnosis of food allergy. They can be 
open, single or double blinded, or placebo controlled. A range of vehicles can be used to 
disguise food (liquids or solid). Tolerance of a serving size of a food is generally considered 
evidence of lack of reactivity. In AD oral food challenges should be performed in a double-
blind placebo-controlled manner (Robinson & Smart, 2008).  
Negative RAST, SPT and APT results have a high negative predictive value and are fairly 
reliable methods of excluding allergy. Positive results however require careful consideration 
and correlation with clinical history and clinical presentation (Robinson & Smart, 2008 & 
Goodwin, 2008).  
2.1 Aeroallergens  
Clinical manifestations of allergy to aeroallergens involve allergic rhinitis, asthma and 
exacerbation of AD. Patients with atopic predisposition can express one or all of these 
clinical manifestations. Filaggrin gene defects have been shown to increase the risk of 
developing allergic sensitization, AD, and allergic rhinitis (Van den Oord & Sheikh, 2009). A 
variety of inhalants have been implicated in exacerbations of AD including house dust mite 
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(HDM), dust mites, HDM feces, animal dander (cat and dog), molds and pollens. 
Sensitization to aeroallergens appears to be more prevalent in older children and adults, 
leading to aggravation of AD after bronchial inhalation. Allergen specific T- cells have been 
identified in affected skin of AD to grass pollen, birch pollen and HDM supporting the 
concept of a T-cell mediated specific immune response to inhalant allergens with clinical 
implications. Sensitization to inhalant allergens is thought to occur via skin as well as 
respiratory route. Allergens penetrate the disturbed epidermal barrier fix on the specific IgE 
present on LCs and activate them. The activated LCs migrate to a lymph node and present 
the allergen to T cells, provoking an eczematous reaction. The appearance of eczematous 
skin lesions is due to cytotoxic T-cell activity and not to the aeroallergen specific IgE. 
Repeated epicutaneous allergen application has been shown to elicit eczematous lesions in 
AD individuals (Reitamo et al., 2008 & Goodwin, 2008).  
 
 
Transcutaneous route 
 
Mite allergen activates LCs via IgE fixation 
Documented presence of HDM on skin 
Induction of eczematous lesions following APT 
 
Respiratory route 
 
Flare up of AD following allergen inhalation 
Induction of new eczematous skin lesions upon allergen inhalation  
 
Table 2. Routes of sensitization aeroallergens in AD 
The respiratory route in the induction of new skin lesions may be relevant in a subset of 
patients with concomitant allergic asthma. Early studies reported that inhalation of house 
dust or pollen extract can provoke exacerbations of AD. Skin lesions have also been shown 
to develop in AD individuals after placebo-controlled bronchial provocation of HDM, cat 
allergen or tree pollen. Aggravation of eczema is more pronounced in AD individuals with 
concomitant allergic asthma than in patients suffering from AD alone. Two possible 
explanations have been offered for this phenomenon. Allergen exposed in airways enters 
the circulation and is transported to skin activating there the inflammatory cascade. Another 
possibility is allergen induced airway inflammation causes release of mediators from 
inflammatory cells in skin already primed for AD. Substantial clinical improvement has 
been reported to occur when sensitized AD individuals are exposed to environments 
lacking the allergens to which they react (Reitamo et al., 2008& Burns et al., 2004).   
Mites belong to the most potent allergen sources and are considered a perennial allergen. 
Thirteen mite species have been identified in house dust so far, the two commonest mites in 
homes worldwide include Dermatophagoides pteronyssimus and Dermatophagoides farinae. Beds 
and overstuffed furniture are main foci for breeding dust mites. Airborne level of mite 
allergen during sleep in bedroom is tenfold higher than that found in living rooms of same 
house during daily activities. Mite allergens persist for months after death of mite. Exposure 
to high doses of mite allergen in early infancy has been associated with higher incidence of 
developing eczema. Efforts to create dust mite free environment yielded significant 
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improvement in clinical symptoms although not complete remission. AD patients not 
sensitized or not exposed to mites benefited as much from exposure to mite free 
environment as those with mite sensitization and/or exposure.  
 
 
• Evidence of aeroallergen specific T cells invading the skin 
• Presence of aeroallergen specific IgE 
• Exacerbation of AD following exposure to aeroallergen 
• Exacerbation of AD following epicutaneous aeroallergen application 
• New skin lesions induced by APT 
• Clinical improvement in aeroallergen poor environment 
 
Table 3. Factors implicating aeroallergens underlying pathomechanism of AD  
Many AD patients are highly sensitized to aeroallergens and experience precipitation of AD 
upon epicutaneous or bronchial allergen exposure. RAST and SPT help to verify or exclude 
the presence of IgE mediated hypersensitivity, by measurement of allergen specific IgE in 
serum and evaluation of IgE bound on mast cells. Neither test procedure considers those 
AD patients characterized by cell-mediated sensitization. The APT was established as a 
provocation test for a subgroup of AD patients to study the induction of eczema by 
aeroallergens after 24-72 hours. It is similar to nasal or bronchial provocation test in allergic 
rhinitis and asthma. Allergen specific IgE is not obligatory for a positive APT reaction. APT 
has shown a higher specificity towards inhalants (69-92%) when compared to SPT (44-53%) 
and serum specific IgE (42-64%), suggesting a more appropriate screening role for SPT and 
RAST in this context. APT does not replace the classical methods of diagnosis of IgE-
mediated allergy. APT are usually negative in individuals with respiratory allergy and 
healthy subjects pointing to AD specific triggering mechanisms required to produce APT 
positivity. Much effort has been undertaken to standardize APT procedures. The protocol of 
the European task Force on Atopic Dermatitis (ETFAD) provides a standardized APT 
technique (Ronchetti et al., 2008). 
Despite above impressive data on APT as a diagnostic tool, final scientific proof for the 
relevance of aeroallergens as identified by positive APT, for clinical manifestation of AD is 
still missing. The question on how well APT can identify AD patients who would benefit 
from allergen avoidance remains to be answered. 
 
 
• Suspicion of aeroallergen symptoms without proof of positive specific IgE or positive 
SPT 
• Severe and/or persistent AD with unknown trigger factors 
• Multiple IgE sensitizations without proven clinical relevance in patients with eczema 
 
Table 4. ETFAD consensus on APT indications 
In summary sensitization to inhalant allergens is a major contributing factor to the 
pathogenesis and perpetuation of AD. It is found more commonly in older children and later 
life of AD individuals and is demonstrated by presence of aeroallergen specific IgE and 
positive SPT to aeroallergens. Bronchial inhalation challenge, RAST, SPT, and APT to 
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aeroallergens, are the main tests available for investigation. Using these tests in combination 
and in consideration of clinical history and signs is likely to yield a higher clinically relevant 
result. Negative results of above investigations are fairly reliable methods of excluding allergy. 
2.2 Food allergens 
The prevalence of AD and food allergies (FA) appears to have increased in recent years in 
many western countries. In this context it is important to define the terms. FA and food 
hypersensitivity (FH) indicate an adverse clinical reaction to food due to interaction of food 
proteins with one or more immune mechanisms. Food intolerance (FI) is the result of non-
immunological reactions to foods and food additives (Reitamo et al., 2008).  
 
 
• Food allergy due to IgE mediated mechanism (Coombs' classification, type I)  
• Food allergy involving other immunological mechanisms ( type IV)  
• Non-allergic food intolerance (pharmacological, metabolic, or toxic reaction to food)  
• Food aversion (often non-specific symptoms, unconfirmed by blinded food 
challenge) 
 
Table 5. Types of adverse reactions to foods  
FA has the greatest incidence in infancy and early childhood. Around 8% of children are 
thought to develop adverse reactions to food, most of them within the first year of life. The 
prevalence of FA varies between regions and is influenced by culture and genetic factors. 
The spectrum of food allergens has remained relatively unchanged despite the rise of FA 
incidence. Seven food items account for 90% of FA in children. These include cow’s milk, 
egg, peanuts, soybeans, wheat, fish, and tree nuts. By three years of age the majority of 
children will have developed tolerance to these food items with the exception of peanuts/ 
tree nuts and seafood. In adults, IgE mediated FA is rare. The main food allergens in adults 
are peanuts, tree nuts, fish and shellfish (Kim, 2008). 
 
Infants and children Adults 
 
Cow’s milk 
Egg 
Peanut 
Tree nuts 
Soy 
Wheat 
Fish 
 
 
Peanut 
Tree nuts 
Fish 
Shellfish 
Table 6. Major food allergens in children and adults 
In general high-protein food allergens are considered to be more allergenic. Most food 
allergens are water-soluble glycoproteins that are particularly resistant to food processing, 
cooking and digestion.  
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Food Item 
 
 
Protein 
Cow’s milk 
 
 
 
 
 
 
 
 
 
 
 
 
Egg white 
 
 
 
 
 
Peanut 
 
 
 
Soy bean 
Caseins
ǂ1-casein 
ǂ2-casein 
ǃ-casein 
κ-casein 
Ǆ-casein 
 
Whey proteins 
ǃ-lactoglobulin 
ǂ-lactalbumin 
Bovine serum 
albumin (BSA) 
 
Ovomucoid 
Ovalbumin 
Ovotransferrin/conalbumin 
Lysozyme 
 
 
Vicillin 
Conglutin 
Glycinin 
 
Gly m 1 
Trypsin inhibitor 
 
Table 7. Common food allergens 
FA in infancy is thought to be due to a failure of the gastrointestinal tract (GIT) to develop 
oral tolerance (OT). No down regulation occurs of GIT immune system in its 
responsiveness towards ingested soluble food antigens. Factors predisposing to impaired 
OT include increased antigen uptake, decreased production of secretory IgA, and an 
imbalance towards Th2 response. Other factors include dose and frequency of antigen 
exposure, biological characteristics of antigens as well as early intestinal inflammation 
affecting gut permeability and mucosal antigen uptake. IgE sensitization can occur as 
early as during fetal period and maternally ingested antigens can be excreted in the breast 
milk. An additional mode of sensitization to food allergens in AD individuals may 
involve the impaired skin barrier function, so that sensitization to food allergens may 
occur even though the food in question has not yet been integrated into the diet (Reitamo 
et al., 2008 & Kim, 2008). 
Immunologically triggered FA can clinically present as immediate (oral allergy syndrome, 
urticaria, angioedema, bronchospasm and anaphylaxis), intermediate (predominantly GIT 
symptoms), and late-onset reactions (AD flares, development of cough and wheeze).  
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• Specific food antigen can be identified  
• Timing of symptoms closely related to food intake  
• Symptoms can involve more than one organ (oral itching and/or swelling, nausea, 
vomiting, abdominal pain, diarrhea, asthma, rhinitis, urticaria, angioedema, 
anaphylaxis)  
• Positive personal or family history of other atopic disorders 
 
Table 8. Factors suggesting classic IgE mediated food allergy 
FA is the earliest manifestation of atopy affecting both breast- and formula-fed infants. Early 
sensitization to food allergens is typically transient. It affects AD individuals mainly in the 
first 2 to 3 years but particularly in the first 12 months of life and is often followed by 
inhalant sensitization as demonstrated by presence of aeroallergen specific IgE and positive 
SPT to aeroallergens. These may in turn contribute to ongoing eczema later in life (older 
children and adults). Multiple studies have established that approximately 35% of children 
with moderate to severe AD have FA. Double-blind placebo-controlled food challenge 
(DBPCFC) is the gold standard for diagnosis of FA. Children with AD, that were assessed 
for FA by DBPCFC showed reactions in 40% of challenges. Of the positive challenges skin 
symptoms occurred in 84% of AD subjects, 56% showed either skin, GIT or respiratory 
symptoms and only 30% developed isolated skin reactions. Children with positive DBPCFC 
were younger than those without. Generally, the younger the patient and the more severe 
the AD, the more likely FA is to be a causative factor (Reitamo et al., 2008 & Kim, 2008). In 
adults with AD IgE-mediated FA plays only a minor role (1-3%). In this group birch pollen 
related food allergens have been shown to be a major predisposing factor. In recent years 
pseudo allergens have been reported to exacerbate symptoms in adults with AD, although it 
is still controversial if these observations always reflect a true pseudo allergic underlying 
pathomechanism. Pseudo allergic reactions are more known in the clinical context of 
urticaria and angioedema. To date no reliable laboratory or skin tests are available to 
diagnose pseudo allergy, so that for the identification of possible pseudo allergen trigger 
factors elimination diet and oral challenge are the norm (Reese et al., 2009). 
Approximately 85% of AD individuals have specific IgE to food- and aeroallergens, making 
diagnosis of FA based on laboratory testing alone inadvisable. The importance of a careful 
history cannot be overemphasized. The history combined with diagnostic tests, should point 
toward a few possible offending foods or groups of food products. Food allergen specific 
IgE is a useful tool in the assessment of FA. A different positive predictive cut off point 
exists for each allergen tested and similar test results do not imply a similar clinical reaction 
to different allergen. Higher levels of specific IgE indicate increased likelihood of allergic 
reaction with exposure. Levels though cannot predict the severity of allergic reaction. In 
general positive RAST results only indicate the presence of IgE to an allergen or cross-
reacting allergen and may not correlate with true clinical reactions. Patients with AD can 
have very high levels of non-specific IgE, which can be detected and give rise to false 
positive results (Robinson & Smart, 2008 & Goodwin, 2008 & Kim, 2008). 
SPT in the diagnosis of FA in infancy is thought to be unreliable. It can provide rapid results 
with high sensitivity, and has a high negative predictive value (>95%), with a negative skin 
test essentially excluding IgE- mediated FA. In contrast the positive predictive value is 
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<50%; suggesting that an isolated positive SPT cannot be predictive for FA. A cut off weal 
diameter of 6-8mm has been demonstrated to be associated with a positive oral food 
challenge (predictive value >95%). In this context SPT can reduce the need for oral food 
challenges by 23% when compared to RAST testing. SPT with fresh fruits and vegetables is a 
better predictor of clinical relevant reaction in comparison to the use of commercial extracts 
for SPT (Robinson & Smart, 2008 & Goodwin, 2008 & Kim, 2008). 
FA in children with AD is thought to be an IgE- and T-cell mediated phenomenon, making 
the use of the APT a useful diagnostic tool. Clinical studies have demonstrated the APT to 
be particularly useful in predicting late-phase clinical reactions. However different studies 
have published contradicting results regarding sensitivity of unstandardized food APT and 
further clinical studies are required for standardization and patient group selection for food 
APT. APT cannot replace oral food challenges. Finally APT in conjunction with positive 
RAST and positive SPT to food allergens has been shown to reliably predict positive food 
challenges (Robinson & Smart, 2008 & Goodwin, 2008 & Kim, 2008 & Ronchetti et al., 2008). 
In summary, a proper dietary and clinical history combined with available testing are more 
likely to yield a clinical relevant result. Involvement of a dietitian is paramount in AD 
patients complaining of FA in order to avoid malnutrition in the long run. 
2.3 Microbial allergens 
Interaction with environmental microbes may be important in the causation of AD in a 
number of ways. Early-life exposure may condition maturation of the immune system so 
that apparent dysregulation associated with IgE production and allergy formation does not 
occur. The possible role of microbes in the early maturation of the immune system may be 
the major factor that could explain the differences between western and developing world 
regarding the incidence of atopy and allergic diseases. Microbes entering via fecal-oral route 
have been shown to have a greater protective effect against development of allergic diseases 
than those entering via respiratory route. Early exposure to Hepatitis A virus, Helicobacter 
pylori or Toxoplasma gondii has been associated with a reduced risk for atopy by 60%. The 
burden of exposure of microbial endotoxins in early infancy is thought to play a major role 
in driving the immune system towards protective responses and away from nuisance 
responses that are associated with allergy (Burns et al., 2004). A number of observations 
suggest the relevance of skin flora in clinical manifestation of AD. In individuals with atopic 
phenotype, eczema may be induced or exacerbated by staphylococcal toxins or by the 
presence of Malassezia yeasts on the skin. 
Staphylococcus aureus is found on the skin of 90% of chronic AD individuals, but only on 5% 
of healthy subjects. When present on healthy normal skin S. aureus is usually low in number 
and mainly confined to intertriginous areas and nasal nares. The presence of S. aureus on 
atopic skin depends on the skin lesion. S. aureus has been isolated in 55-75% of clinically 
unaffected AD skin, 85-91% of chronic lichenified lesions and 80-100% of acute exsudative 
eczematous lesions. The density of S. aureus on acutely inflamed AD skin can be 1000-fold 
higher than on uninvolved skin in AD individuals suggesting a good correlation between 
the degree of bacterial colonization and clinical disease severity  
The ability of S. aureus to cause human disease is dependent on production of cell surface 
adhesions, antiphagocytic factors and secreted exotoxins, whose function appear to be both 
securing nutrient for microbes and delaying function of immune system. Among the factors 
secreted by S. aureus is the large family of superantigen exotoxins.  
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The factors influencing colonization and infection of S. aureus in AD skin are not yet well 
understood and likely to be multifactorial. Defective skin barrier function, reduced content 
of skin lipids, loss of certain innate antibacterial activities via changes of antibacterial 
peptides on skin, and a more alkaline pH of skin surface are all thought to play a role in this 
context. Antimicrobial peptides such as ǃ-defensins and cathelicidins are critical elements of 
the skin’s innate immunity. These peptides eliminate not only S. aureus, but also fungal, 
viral and other bacterial pathogens. The decreased antimicrobial peptide levels in AD skin 
are not caused by intrinsic defect in keratinocyte production but rather to inhibition 
mediated by the Th2 cytokine milieu in the AD microenvironment (Schlievert et al., 2008). 
Scratching disturbs the epidermal barrier and releases pro-inflammatory cytokines that up 
regulate the extracellular matrix molecules to act as adhesins to S. aureus. Cracks in the skin 
expose underlying extracellular matrix molecules to S. aureus attachment (Reitamo et al., 2008). 
 
 
• Disturbed skin barrier and function 
• Reduced content of skin lipids  
• pH of skin surface more alkaline 
• Increased adherence of S. aureus to skin due to raised fibronectin and fibrinogen (so 
called adhesins)  
• Reduced keratinocyte production of ǃ-defensins and LL-37 (antimicrobial peptides) 
 
Table 9. Factors influencing colonization and infection with S. aureus in AD 
Staphylococcal super antigens include staphylococcal enterotoxins, classically the common 
cause of food poisoning and non menstrual toxic shock syndrome (TSS), and TSS toxin1 
(TSST-1), the cause of both menstrual and non menstrual TSS. Staphylococcal enterotoxin 
serotypes A-E (SEA-SEE) and SEG-SEQ are well documented in the literature. Super 
antigens are defined by their ability to stimulate cytokine release from both T cells and 
macrophages. They bind directly without antigen processing to constitutively expressed 
HLD-DR molecules on professional antigen-presenting cells precipitating marked T cell 
stimulation (Macias et al., 2011). 
Most AD individuals show raised specific IgE levels in serum against staphylococcal 
superantigens and rarely make IgE against constituents of S. aureus cell wall. They also 
demonstrate super antigen specific IgE on their skin. Basophils from patients with 
superantigen specific IgE release histamine on exposure to relevant superantigen, but not 
when exposed to super antigens they are not sensitized to. A correlation between 
presence of superantigen specific IgE and clinical AD severity has been identified and 
colonization with superantigen producing S. aureus is greatest with IgE to staphylococcal 
superantigen. Skin homing peripheral T cells have also been shown to respond to 
superantigen and contribute to eosinophilia and IgE production in AD. Epicutaneous 
application of SEB to unaffected AD skin is followed by exacerbation of eczema 
suggesting that superantigens can precipitate and sustain the dermal inflammatory 
cascade in AD individuals. Combined treatment of AD with antibiotics and 
corticosteroids is more effective than corticosteroid treatment alone suggesting that S. 
aureus secrets products that can induce steroid resistance (Schlievert et al., 2008). In a 
recent study S. aureus strains isolated from steroid resistant AD showed an ability to 
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produce larger numbers of superantigen types per organism. There was also dysregulated 
production of super antigens and production of unusual superantigen combinations. 
Reduction of S. aureus on AD skin controls the skin inflammation which predisposes to S. 
aureus colonization and/or infection. Discrepancies in antibiotic sensitivity pattern have 
been documented among S. aureus strains colonizing different sites of AD skin (affected 
and unaffected) and also in AD individuals with prior antibiotic therapy. Repeat 
microbial susceptibility testing on different body sites is therefore recommended 
(Kedzierska et al., 2008).  
 
 
• Efficacy of topical antiseptic treatment 
• Efficacy of topical antibiotic therapy 
• Efficacy of application of gammaglobulins 
• Efficacy of oral antibiotic and antifungal therapy 
 
Table 10. Relevance of skin flora for AD 
In recent years there is an increasing body of evidence suggesting that yeasts particularly of 
the genera of Malassezia and Candida can be relevant for AD pathogenesis. Many studies 
have demonstrated colonization of AD skin with Malassezia yeasts with subsequent 
deterioration of clinical disease (Darabi et al., 2009). Malassezia yeasts are members of the 
normal human skin flora, and often associated with different dermatological disease. The 
concentration of yeasts on skin does not have to be raised in AD individuals, suggesting that 
skin barrier dysfunction and typical changes in skin inflammatory response in AD play a 
major role. Great variation in density and presence of Malassezia yeasts in different sites of 
AD skin has been documented with the highest concentrations affecting the scalp and upper 
trunk and the lowest on hands. Sensitization to Malassezia yeasts have been exclusively 
demonstrated in AD individuals, via SPT with Malassezia extracts and the presence of 
Malassezia specific IgE antibodies. The density of the yeasts reduces with progressing age, 
although the yeast cells are larger in adults than in children. Malassezia specific IgE in serum 
has been identified in 20-100% of AD subjects depending on trial. Prevalence was highest in 
adults with head and neck AD (HNAD) and lowest in children with AD. A strong 
correlation between Malassezia specific IgE levels and severity of HNAD has been found, 
with Malassezia specific IgE being a good marker for HNAD (Darabi et al., 2009). Positive 
SPT to Malassezia extracts have been reported in 13.5-79% of AD individuals, compared to 
small minority in individuals with other Malassezia induced skin conditions. This suggests 
an exclusive presence of Malassezia sensitization in AD subjects. Malassezia antigens have 
been used to APT in some trials and positive results were observed in AD patients 
suggesting a possible role of Malassezia yeasts in eliciting and perpetuating eczema in 
already sensitized AD individuals (Reitamo et al., 2008 & Darabi et al., 2009).  Malassezia 
extracts are not yet part of the standardized APT panel provided by ETFAD. No consistent 
correlation has been shown between HNAD and positive APT. In many trials oral 
antifungal therapy has been shown to improve clinical manifestations of AD, particularly in 
the context of HNAD, exacerbations during adolescence and young childhood, severe AD 
recalcitrant to conventional therapy, and presence of other atopic diseases. It is not clear yet 
if this is due to the anti-inflammatory effects of antifungals or due to their antifungal 
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properties. Despite the available positive data on Malassezia species and AD there is not 
convincing proof for the importance of this yeast in AD pathogenesis. Malassezia 
sensitization has been reported in both types of AD, extrinsic and intrinsic, and skin barrier 
dysfunction in AD enabling easier access and therefore cross reactivity between human and 
fungal manganese superoxide dismutase might be another explanation for the sensitization 
to Malassezia yeasts seen in AD. 
Colonization with Candida albicans has been found in higher numbers on involved and 
uninvolved skin of AD individuals than on normal subjects. More importantly colonization 
of the gastrointestinal tract with Candida yeasts was identified in 70% of AD patients 
compared to 54% of healthy volunteers. 22-94% of AD individuals have shown positive SPT 
to C. albicans and positive correlation existed between the number of positive SPTs and 
clinical disease severity. C. albicans specific IgE has been reported in 25-88% of AD patients 
and cross reactivity to Malassezia has been described. Interestingly PT with C. albicans 
extracts have shown fewer positive results than the healthy controls. In summary the 
evidence on C. albicans is too small to allow any conclusions about its role in AD 
pathogenesis (Reitamo et al., 2008). 
2.4 Autoallergens 
IgE autoreactivity has been implicated in the immune pathogenesis and in particular 
perpetuation of AD. Striking similarities between environmental allergens and human 
proteins have been identified on molecular analysis of allergens, and IgE-reactive 
autoantigens against human proteins have been cloned from human epithelial copy DNA 
expression libraries. Autoantigens have been detected in IgE-mediated immune complexes 
in serum of AD individuals and release of autoallergens following tissue (skin barrier) 
damage has been reported. More importantly reduced levels of IgE autoallergen levels have 
been noted following successful treatment of AD. It is possible that following initiation of 
the AD immune and inflammatory cascade in skin and peripheral blood by environmental 
allergens, these mechanisms are then partially perpetuated by autoallergens. More studies 
are required in the future to allow any sensible conclusion (Reitamo et al., 2008).  
2.5 Contact allergens  
It is clear that AD individuals are at greater risk in developing irritant contact dermatitis 
than non-atopic subjects, as contact allergens are likely to penetrate the defective skin 
barrier more easily. In this context hand eczema has been reported to occur in higher 
frequency in AD patients. AD individuals, who are particularly employed in occupations 
involving wetwork are prone to develop an intractable hand dermatitis in their occupational 
setting leading to considerable occupational disability. Urticaria is frequently encountered 
in AD individuals, and an allergic basis is found more often in atopic subjects than in the 
normal population. Contact urticaria of hands may lead to exacerbation of clinical disease in 
AD particularly in food handlers and slaughterhouse workers (food allergens) as well as 
health care workers (latex protein sensitivity) (Burns et al., 2004).  
There has been dispute about whether atopic individuals are at greater risk to developing 
contact allergic reactions. CAD has a reported prevalence of as high as 28% in certain 
European countries, and similarity in clinical symptoms between AD and CAD makes 
correct diagnosis of CAD a challenge and can easily lead to misdiagnosis. A recent PT study 
found that a family history of AD (85%), female sex (74%), and age 11-16 (63%) were 
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predisposing risk factors to contact allergen sensitization. Another study evaluating contact 
sensitization in a series of atopic pediatric patients, that were patch tested, identified 43% 
positive reactions without commenting on clinical relevance of these reactions (Fonacier & 
Aquino, 2010 & Jacob S et al., 2008). AD individuals can develop sensitivity to a variety of 
contact allergens such as topical medicaments including emollients and corticosteroids as 
well as fragrances, particularly in the presence of recalcitrant periorbital dermatitis. A 
positive past medical history of AD (44% in patients with periorbital dermatitis) has been 
found to be a predisposing factor for periorbital dermatitis when compared with all patch-
tested individuals (29% with peri-orbital dermatitis). Statistically significantly more patients 
with AD were found in the group of patients with than without periorbital dermatoses. The 
periorbital region is a prime location for AD and in consequence a defective skin barrier 
alleviates sensitization to contact allergens as well as aeroallergens. 
Hand eczema and compositae allergy may be more common in AD, whereas allergies to 
topical corticosteroids and antiseptic solutions are only positive in a small subset of AD 
patients (15%) (Fonacier & Aquino, 2010).  
Oat sensitization and its clinical manifestations  in the form of digestive, respiratory and 
cutaneous symptoms (including CAD) has been identified  in 15-20% of AD children, 
compared to none in the normal population. It is likely to be due to repeated applications of 
oat proteins through topical emollients and hygiene products on a predisposed impaired 
epidermal skin barrier of AD individuals. Oat can also be added to the list of food products 
(e.g. peanut, ovalbumin, almond) responsible for FA triggered by a possible percutaneous 
sensitization. Avoiding application of topical containing oat protein products in AD infants 
is paramount in reducing sensitization to oat (Boussault P et al., 2007).  
 
 
• New-onset dermatitis 
• Progression or deterioration of existing dermatitis (AD/Psoriasis) 
• Recalcitrant dermatitis by standard therapies 
• Clinical presentation of dyshidrosis 
 
Table 11. Factors that make a diagnosis of CAD likely  
A lower frequency of positive quinoline allergy has been documented in AD individuals, 
whereas contact allergy to neomycin among atopic subjects is usually found to be equivalent 
or slightly raised in comparison to non-AD individuals. AD subjects appear to have 
increased efficiency in orally tolerising haptens but are inefficient in orally tolerising 
proteins. The reduced contact allergy to quinoline in AD patients might be explained by a 
higher exposure of haptens in the gut and skin at a young age producing “hapten”-tolerance 
(McFadden & White, 2008).  
History for CAD should always include the patient’s personal hygiene environment, 
medical and medicament history as well as home and care giver environment. PT should be 
performed in all AD patients where CAD is considered and particularly in children with 
AD. However because of irritancy interpretation of PT may be difficult in AD individuals 
and the severity of AD might have an impact on the results obtained through PT. PT should 
always include the emollients used.  
In summary more and more studies suggest, that CAD might occur as common in AD 
individuals and particularly in children with AD as in the general population. 
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Consideration of CAD is recommended in each case of recurrent and recalcitrant clinical 
disease, and PT should be considered and offered to AD patients in those circumstances. 
However the relevance between a positive PT reaction and clinical severity of AD remains 
to be answered.  
3. Conclusion 
AD is a common chronic skin condition associated with high morbidity and major public 
health implications. As prevention of disease is not yet a real option, reducing morbidity is 
main aim of treatment. Identifying the underlying pathomechanism of the individual’s AD 
is very crucial. High levels of specific IgE antibodies and or total IgE levels in serum are 
significantly associated with severity of dermatitis in individuals with the extrinsic type of 
AD. Raised specific IgE antibodies can be detected in the peripheral blood for most trigger 
factors and allergens. Food and aeroallergens, microbes including S. aureus and Malassezia 
yeasts, contact allergens and autoallergens have been identified to trigger AD and 
perpetuate so the underlying immune and inflammatory cascade of AD.   
To date no standard test is available to diagnose AD. Sensitization to various allergens is a 
major part of triggering and perpetuating the inflammatory skin response in AD. Various 
tests have been developed to investigate the underlying type(s) of hypersensitivity reaction 
involved in AD patients. None of the available tests so far have proven sensitive and specific 
enough to identify reliably relevance between clinical reaction and test result. Allergy tests 
commonly used in practice include measurement of total levels of IgE and allergen specific 
IgE levels in serum (RAST), SPT, APT, PT and DBPCFC.  
Precise understanding of these tests including their limitations together with accurate 
correlation of patient history, symptoms and signs are required in order to differentiate 
between allergy, intolerances and hypersensitivities, and achieve an appropriate clinical 
diagnosis. Results must always be interpreted in the context of clinical history. 
In a recent meta-analysis filaggrin gene defects have shown to increase the risk of 
developing allergic sensitization, AD, and allergic rhinitis. The presence of filaggrin gene 
mutations correlated strongly with disease severity and treatment failure, and also increased 
the risk of asthma in AD patients. Gene testing for filaggrin gene mutations might be an 
additional way to identify atopic individuals in future.  Restoring skin barrier function in 
filaggrin deficient individuals early in life may help prevent the development of 
sensitization and halt the development and progression of allergic disease. 
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